Prolong Pharmaceuticals
- Biotech or pharma, therapeutic R&D
Prolong is a late clinical-stage, New Jersey based biopharmaceutical company advancing its novel oxygen transfer agent, PP-007 in acute ischemic stroke, ready for phase 3 pivotal development.
Address
South PlainfieldNew Jersey
United States
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}